New Low Ahead? Idera Pharmaceuticals Inc (NASDAQ:IDRA)

Idera Pharmaceuticals Inc (NASDAQ:IDRA) has been trading around its 52-week low.

Market Action

As of 10:10 IDRA is trading at 1.02. down .04 losing 3.7% so far on the day. Volume is 257k shares. IDRA opened at 1 and has traded in a range between 1.00 and 1.05.

Idera Pharmaceuticals Provides Updates

  • IDRA will discontinue the trail of tilsotolimod in combination with ipilimumab versus ipilimumab alone in patients with anti-PD-1 refractory advanced melanoma, to its overall survival (OS) primary endpoint
  • Tilsotolimod with ipilimumabis not expected to achieve a statistically significant OS benefit over ipilimumab alone
  • The trial failed to meet the expected results as announces in March
  • Full results from the study will be presented in a future publication

CEO Vincent Milano commented “We remain committed to our additional trials and are continuing to enroll and treat patients in ILLUMINATE-206, our Phase 2 study of tilsotolimod in combination with BMS’s nivolumab and ipilimumab for patients with microsatellite-stable colorectal cancer and to support AbbVie in the form of study drug in their trial for patients with head and neck squamous cell carcinoma.”

Trader Notes

Share Information

SHARE FLOAT (%) 38.71 M (77.37%)

Recent Stock Performance

5-DAY PERF. -1.85%
1-MONTH PERF. -3.64%
3-MONTH PERF. -78.14%
6-MONTH PERF. -68.17%
YTD PERF. -71.12%
1-YEAR PERF. -41.44%

Moving Averages

+/- EMA(20) 1.16 (-8.62%)
+/- SMA(50) 1.82 (-41.76%)
+/- SMA(200) 3.06 (-65.36%)

Pivot Points

Name S3 S2 S1 Pivot Points R1 R2 R3
Classic 1.0133 1.0267 1.0433 1.0567 1.0733 1.0867 1.1033
Fibonacci 1.0267 1.0381 1.0452 1.0567 1.0681 1.0752 1.0867

Technical Indicators

Symbol Value Result Symbol Value Result
ADX 12.8340 Neutral ATR14 0.1387
CCI20 -57.2276 Sell Chaikin Money Flow 0.1416 Buy
MACD -0.4439 Sell Money Flow Index 32.4252 Sell
ROC -10.1695 Sell RSI 46.2566 Buy
STOCH (14,3) 30.7958 Sell STOCH RSI 1.0000 OverBought
UO 51.6717 Buy Williams %R -69.2042 Neutral

Related Posts

About The Author